Mammography

Philips received FDA 510(k) clearance for MicroDose SI, a full-field digital mammography system that enables future Single-Shot Spectral Imaging applications.

Breast density can be accurately scored with images obtained through either digital mammography or film-screen mammography.

Mammograms every two years are just as beneficial to women over 65 as are annual exams - and may reduce false positives.

Early breast tomosynthesis adopter Washington Radiology Associates increased cancer detection by one-third, decreased call-backs, and improved provider confidence.

Bilateral dual-energy contrast agent-enhanced digital mammography is as effective as MRI in detecting known primary breast tumors.

CHICAGO - Breast cancer risk estimates increase with frequent CT scans, particularly among younger patients, researchers found.

Three-dimensional imaging with breast tomosynthesis increases diagnostic accuracy and reduces false positive recall rates.

Stereoscopic digital mammography, a new 3D technique, significantly improves the accuracy of breast cancer detection in high-risk women.

Digital mammography is better for detecting life-threatening breast cancers than is screen film mammography, without increasing overdiagnosis.

Adding digital breast tomosynthesis to digital mammography significantly increases the accuracy of the mammography, compared with full-field digital mammo.

GE Healthcare and RadNet have partnered to identify the most efficient, cost-effective approaches for breast cancer detection.

Breast cancer mortality can drop significantly among women who undergo screening.

Women with mutations to the BRCA1/2 genes who undergo diagnostic chest radiation before age 30 are at a higher risk of developing breast cancer.

Breast Imaging and Reporting Data Systems terminology is useful in predicting malignancy in breast lesions that are detected by MRI.

The non-radiation based imaging modality is not a reliable breast cancer screening tool and mammography should remain the standard of care.

Preoperative MRIs should be done on all newly diagnosed breast cancer patients, regardless of breast density.

Digital breast tomosynthesis plus mammography provides a 40 percent reduction in patient recalls, reducing anxiety and potentially cutting cost and overall radiation dose.

Radiation doses from digital breast tomosynthesis is comparable to and could be lower than conventional two-view full-field digital mammography.

In this podcast, Stephen Rose, MD, president and CEO of Houston Breast Imaging and a principal investigator of the 3-D tomosynthesis clinical trials in 2010, discusses the benefits of the new technology and what his practice learned when implementing the screening program.

Giotto USA will be demonstrating at RSNA 2011 its 3D and 3DL digital mammography systems, which recently received FDA 510(k) clearance.

Philips will highlight its newly released MicroDose Mammography System at RSNA 2011. The Philips unit will go head to head with other new entries in the mammography space including Hologic’s 3-D breast tomosynthesis product, Selenia® Dimensions, whole breast ultrasound from U-Systems, Dilon’s 6800 MBI scanner, and GE’s Discovery MB750b, a molecular breast imaging system.

In this podcast, Tom Gentile, president and CEO at GE Healthcare Systems, explains that “the whole focus of imaging is moving beyond the quality of the image.” Patient care, physician productivity and reimbursement take on a renewed focus in light of healthcare reform efforts internationally, he says.

Calling the results flawed, many in the radiology community are protesting a study released last week that suggested mammography hasn’t played a major role in the drop in breast cancer-related deaths.

Thermography not a replacement for mammography

Imagine a faster, inexpensive method for breast cancer screening. That’s some of the promise behind a new innovation from doctoral student, Sevan Goenezen, who has discovered a way to use ultrasound and advanced algorithms to differentiate between benign and malignant tumors.